What is Prothotic Laboratories?
Based in Farmingdale, New York, Prothotic Laboratories, Inc. operates as a premier facility dedicated to the design and fabrication of customized orthotic and prosthetic solutions. With a legacy spanning over three decades, the firm distinguishes itself through the integration of high-quality materials and cutting-edge technology to address complex mobility challenges for both pediatric and adult populations. Their clinical portfolio includes specialized scoliosis bracing and bespoke prosthetic devices, supported by a team of board-certified specialists. By maintaining a rigorous focus on patient-centric outcomes, the company has established itself as a vital provider in the regional healthcare ecosystem, bridging the gap between clinical necessity and technological innovation.
How much funding has Prothotic Laboratories raised?
Prothotic Laboratories has raised a total of $332K across 2 funding rounds:
Debt
$150K
Debt
$182K
Debt (2020): $150K with participation from PPP
Debt (2021): $182K led by PPP
Key Investors in Prothotic Laboratories
PPP
Public-Private Partnership
What's next for Prothotic Laboratories?
With the recent capital deployment, Prothotic Laboratories is strategically positioned to optimize its manufacturing workflows and broaden its reach across the New York metropolitan area. The focus will likely shift toward the adoption of next-generation additive manufacturing techniques and the expansion of its clinical specialist network to meet rising demand for personalized mobility aids. Furthermore, the firm is expected to leverage this financial stability to deepen its research and development initiatives, ensuring that its prosthetic and orthotic offerings remain at the forefront of medical technology. As the company matures, the emphasis will remain on scaling operational efficiency while upholding the high standards of care that have defined its thirty-year history.
See full Prothotic Laboratories company page
